Why Startups Marketing Prescription Drugs Need to Tread Carefully: Term Sheet for Tuesday, April 16

Apr 16, 2019 - Fortune
Mergers and Acquisitions

Ro, a direct-to-consumer telehealth business, is raising another round of funding. According to TechCrunch, the company is raising $85 million in Series B funding at a $500 million valuation. It's unclear who participated in the latest financing, but Ro's prior investors include FirstMark Capital, SignalFire, Initialized Capital, General Catalyst, Slow Ventures, Sinai Ventures, Torch Capital, BoxGroup, and Tusk Ventures.

You may remember that I wrote about Ro's last $88 million fundraise j...